Will, can you elaborate on P3 completing in an "at home phase", is that even possible. Or are you saying it would be focused on a sub-set of pre-defined/selected users, BEFORE announcing a completed trial?
Just trying to understand the estimated path here. If the above scenario is something that would track between IPIX and FDA. Would IPIX be allowed to collect revenue prior to completion of P3 trial? I don't think so in this case.
Therefore, the partnering and funding from a BP/GOV track would be that more important.
Thanks.
News 
Market Data 
Discover 
AI
